IBRT20063 / EF-32 / Nimish Mohile
Research Question:
not to be listed
Basic Study Information
Purpose:
To test the effectiveness and safety of Optune® given concomitantly with radiation
therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM patients, compared to radiation
therapy and temozolomide alone. In both arms, Optune® and maintenance temozolomide
are continued following radiation therapy.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Nimish Mohile
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search